Targeting tumour-associated macrophages (Q36936355)

17 August 2017

1 reference

title

Targeting tumour-associated macrophages (English)

1 reference

17 August 2017

10

1 reference

17 August 2017

Paola Larghi

4

0 references

Massimo Locati

object named as

Massimo Locati

8

0 references

Chiara Porta

object named as

Chiara Porta

5

0 references

author name string

Antonio Sica

1

1 reference

17 August 2017

Luca Rubino

2

1 reference

17 August 2017

Alessandra Mancino

3

1 reference

17 August 2017

Monica Rimoldi

6

1 reference

17 August 2017

Graziella Solinas

7

1 reference

17 August 2017

Paola Allavena

9

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Expert Opinion on Therapeutic Targets

17 August 2017

1 reference

17 August 2017

11

1 reference

17 August 2017

9

1 reference

17 August 2017

1219-1229

1 reference

Inflammation and cancer: back to Virchow?

17 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Altered macrophage differentiation and immune dysfunction in tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Analysis of mannose receptor regulation by IL-4, IL-10, and proteolytic processing using novel monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Monocyte and macrophage heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Macrophage polarization comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Diminished expression of transcription factors nuclear factor kappaB and CCAAT/enhancer binding protein underlies a novel tumor evasion mechanism affecting macrophages of mammary tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

HIF-1alpha is essential for myeloid cell-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Regulation of the chemokine receptor CXCR4 by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

The origin and function of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

The role of SHIP1 in macrophage programming and activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Nf-kappa B, chemokine gene transcription and tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypox

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

p50 Nuclear Factor- B Overexpression in Tumor-Associated Macrophages Inhibits M1 Inflammatory Responses and Antitumor Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.9.1219

10.1517/14728222.11.9.1219

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference